The first case was an arthroscopic ankle fusion, according to a news release. OssiGraft Prime is derived from donors with a median age of 35 and a maximum age of 55, and it has a high composition of cancellous bone to promote faster bone regeneration.
OssiGraft Prime is available nationwide to orthopedic surgeons.
